Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Intravenous immunoglobulin-induced hemolytic anemia after thoracoscopic thymectomy for myasthenia gravis.

Tsukada H, Sunkara R, Chi DD, Keogh D, Gaissert H.

Ann Thorac Surg. 2014 Jun;97(6):2175-7. doi: 10.1016/j.athoracsur.2013.08.024.

PMID:
24882299
2.

Triple-negative breast cancers are increased in black women regardless of age or body mass index.

Stead LA, Lash TL, Sobieraj JE, Chi DD, Westrup JL, Charlot M, Blanchard RA, Lee JC, King TC, Rosenberg CL.

Breast Cancer Res. 2009;11(2):R18. doi: 10.1186/bcr2242. Epub 2009 Mar 25.

3.

Clinical significance of circulating DNA microsatellite markers in plasma of melanoma patients.

Nakayama T, Taback B, Nguyen DH, Chi DD, Morton DL, Fujiwara Y, Hoon DS.

Ann N Y Acad Sci. 2000 Apr;906:87-98. No abstract available.

PMID:
10818602
4.

Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.

Fujiwara Y, Chi DD, Wang H, Keleman P, Morton DL, Turner R, Hoon DS.

Cancer Res. 1999 Apr 1;59(7):1567-71.

6.

Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.

Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, Hoon DS.

J Clin Oncol. 1998 Aug;16(8):2632-40.

PMID:
9704713
7.

Cellular immuno-PCR. Detection of a carbohydrate tumor marker.

Zhang Z, Irie RF, Chi DD, Hoon DS.

Am J Pathol. 1998 Jun;152(6):1427-32.

8.

Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine.

Okamoto T, Kaneda Y, Yuzuki D, Huang SK, Chi DD, Hoon DS.

Gene Ther. 1997 Sep;4(9):969-76.

9.

Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.

Chi DD, Merchant RE, Rand R, Conrad AJ, Garrison D, Turner R, Morton DL, Hoon DS.

Am J Pathol. 1997 Jun;150(6):2143-52.

10.

Melanoma-associated antigens as messenger RNA detection markers for melanoma.

Sarantou T, Chi DD, Garrison DA, Conrad AJ, Schmid P, Morton DL, Hoon DS.

Cancer Res. 1997 Apr 1;57(7):1371-6.

11.

Detection of metastatic breast cancer by beta-hCG polymerase chain reaction.

Hoon DS, Sarantou T, Doi F, Chi DD, Kuo C, Conrad AJ, Schmid P, Turner R, Guiliano A.

Int J Cancer. 1996 Oct 21;69(5):369-74.

12.

Detection of beta-human chorionic gonadotropin mRNA as a marker for cutaneous malignant melanoma.

Doi F, Chi DD, Charuworn BB, Conrad AJ, Russell J, Morton DL, Hoon DS.

Int J Cancer. 1996 Feb 8;65(4):454-9.

13.

Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.

Wells SA Jr, Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton SB, Ivanovich JL, DeBenedetti MK, Dilley WG, Moley JF, et al.

Ann Surg. 1994 Sep;220(3):237-47; discussion 247-50.

14.

Predictive testing for multiple endocrine neoplasia type 2A (MEN 2A) based on the detection of mutations in the RET protooncogene.

Chi DD, Toshima K, Donis-Keller H, Wells SA Jr.

Surgery. 1994 Aug;116(2):124-32; discussion 132-3.

PMID:
7914034
15.

Three dinucleotide repeat polymorphisms closely linked to the RET protooncogene D10S1098, D10S1099 and D10S1100.

Carlson KM, Dou S, Toshima K, Chi DD, Donis-Keller H.

Hum Mol Genet. 1994 Jul;3(7):1207. No abstract available.

PMID:
7981703
16.

Two chromosome 7 dinucleotide repeat polymorphisms at gene loci epidermal growth factor receptor (EGFR) and pro alpha 2 (I) collagen (COL1A2).

Chi DD, Hing AV, Helms C, Steinbrueck T, Mishra SK, Donis-Keller H.

Hum Mol Genet. 1992 May;1(2):135. No abstract available.

PMID:
1301150

Supplemental Content

Support Center